Tag: Maria Caulfield

  • Maria Caulfield – 2016 Parliamentary Question to the Department of Health

    Maria Caulfield – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Maria Caulfield on 2016-01-04.

    To ask the Secretary of State for Health, what steps he is taking to improve one year cancer survival rates over the next five years.

    Jane Ellison

    The independent Cancer Taskforce’s five-year strategy for cancer, Achieving World-Class Cancer Outcomes, published in July 2015, recommends improvements across the cancer pathway with the aim of improving survival rates. NHS England has appointed Cally Palmer as NHS National Cancer Director. She will lead on the implementation of the strategy, as well as new cancer vanguards to redesign care and patient experience.

    She is currently setting up a new Cancer Transformation Board to lead the roll-out of the recommendations of the new strategy, and a Cancer Advisory Group, chaired by Dr Harpal Kumar, Chief Executive of Cancer Research UK, will oversee and scrutinise their work. Timeframes and phasing for implementation will be dependent on the final financial settlement reached as a result of the spending review.

    We announced in September 2015 that Health Education England (HEE) is developing a new national training programme for an additional 200 staff to get the skills and expertise to carry out endoscopies by 2018. The content of the next mandate from the Government to HEE is currently being determined.

    A commitment to whole-person care for patients, including those living with and beyond cancer, is embedded throughout the cancer taskforce report. In addition, the cancer vanguards have been established to explore new models of care, with a focus on delivering more person-centred care.

    Ensuring the National Health Service is able to support the availability and use of effective treatments and medicines for rare cancers is a key priority. Cancer 52, an organisation which specifically represents patients with rarer cancers, was represented on the independent Cancer Taskforce. The Taskforce’s report made many recommendations relevant to rarer cancers, focussing in particular on improving access to diagnostic testing, including fast, direct general practitioner access to key blood tests, and increasing patient access to the most advanced treatments.

  • Maria Caulfield – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    Maria Caulfield – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Maria Caulfield on 2016-03-21.

    To ask the Secretary of State for Foreign and Commonwealth Affairs, what reports his Department has received on the rebuilding by Hamas of its cross-border tunnel infrastructure into Israel.

    Mr Tobias Ellwood

    We are aware of reports of Hamas rebuilding tunnels and we remain deeply concerned by Hamas’ attempts to rearm and rebuild infrastructure, including the tunnel network in Gaza. Any Hamas rearmament undermines efforts to improve the situation in Gaza and harms prospects for peace and stability in the Middle East.

  • Maria Caulfield – 2016 Parliamentary Question to the Department of Health

    Maria Caulfield – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Maria Caulfield on 2016-01-22.

    To ask the Secretary of State for Health, what steps his Department plans to take to monitor and evaluate the effect of the men who have sex with men human papilloma virus vaccination programme.

    Jane Ellison

    In November 2015, the Joint Committee on Vaccination and Immunisation (JCVI) advised that a targeted human papilloma virus vaccination programme for men who have sex with men attending genito-urinary medicine and HIV clinics should be undertaken, subject to procurement of the vaccine and delivery of the programme at a cost-effective price. The Department and Public Health England are considering the JCVI’s advice, including how such a programme could be monitored and evaluated.

  • Maria Caulfield – 2016 Parliamentary Question to the Department of Health

    Maria Caulfield – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Maria Caulfield on 2016-03-23.

    To ask the Secretary of State for Health, whether he plans to encourage uptake of sight tests amongst children and adults with learning disabilities in the Learning Disability Action Plan.

    Alistair Burt

    The Department is coproducing the learning disability action plan with self-advocates, family carers and other experts and stakeholders. It will support people with learning disabilities of any age and level of need being able to live good and fulfilling lives with the opportunities that other people have. This includes people being able to access health and care services in the right place at the right time. The programme of sight tests in special schools underway in London commissioned by NHS England from See Ability will provide evidence on access to sight tests by people with learning disabilities.

  • Maria Caulfield – 2016 Parliamentary Question to the Department of Health

    Maria Caulfield – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Maria Caulfield on 2016-01-22.

    To ask the Secretary of State for Health, when human papilloma virus vaccinations will be available to men who have sex with men through genito-urinary medicine clinics; and what steps his Department is taking to promote that availability.

    Jane Ellison

    In November 2015, the Joint Committee on Vaccination and Immunisation (JCVI), the expert body that advises the Government on all immunisation matters, advised that a targeted human papillomavirus vaccination programme should be undertaken for men who have sex with men up to 45 years of age who attend genitourinary medicine and HIV clinics. They noted that this should be subject to procurement of the vaccine and delivery of the programme at a cost-effective price.

    The Department is considering the JCVI’s advice and is undertaking a full equality analysis. The Department will confirm its plans in due course.

  • Maria Caulfield – 2016 Parliamentary Question to the Department of Health

    Maria Caulfield – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Maria Caulfield on 2016-03-23.

    To ask the Secretary of State for Health, whether he plans to encourage uptake of sight tests amongst children and adults with learning disabilities in the Learning Disability Action Plan.

    Alistair Burt

    The Department is coproducing the learning disability action plan with self-advocates, family carers and other experts and stakeholders. It will support people with learning disabilities of any age and level of need being able to live good and fulfilling lives with the opportunities that other people have. This includes people being able to access health and care services in the right place at the right time. The programme of sight tests in special schools underway in London commissioned by NHS England from See Ability will provide evidence on access to sight tests by people with learning disabilities.

  • Maria Caulfield – 2016 Parliamentary Question to the Department of Health

    Maria Caulfield – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Maria Caulfield on 2016-01-22.

    To ask the Secretary of State for Health, whether his Department plans to extend the age group entitled to receive the human papilloma virus vaccinations for women.

    Jane Ellison

    The human papillomavirus (HPV) vaccination programme for girls was introduced in 2008, on the recommendation of the Joint Committee on Vaccination and Immunisation (JCVI), the expert body that advises the Government on all immunisation matters. The aim of the programme is to prevent cervical cancer related to HPV infection.

    When the routine programme was introduced in 2008, a catch-up programme was also rolled out to offer the vaccine to women up to age 18 years. This was also based on advice from the JCVI that the catch-up, as well as the routine programme, would be cost-effective.

    The JCVI also noted that ‘catch up’ vaccination for women aged 18 to 25 years was not cost-effective at the vaccine price considered and, on this basis, did not advise the routine vaccination of women beyond the age 18. In 2015, the JCVI revisited the issue and noted that the cost-effectiveness of a catch-up programme for women above 18 years who had not received the vaccine was considered unlikely to be cost-effective. On this basis, we do not have any plans to offer HPV vaccine routinely to women aged 18 and over at this time. Clinicians are however able to offer vaccinations outside of the national programme to women at high risk using individual clinical judgement.

  • Maria Caulfield – 2016 Parliamentary Question to the Department for Transport

    Maria Caulfield – 2016 Parliamentary Question to the Department for Transport

    The below Parliamentary question was asked by Maria Caulfield on 2016-04-08.

    To ask the Secretary of State for Transport, how many times Southern Trains has cancelled a scheduled stop at Plumpton Station in East Sussex in the last 12 months for which information is available.

    Claire Perry

    We do not hold information to this level of detail. Govia Thameslink Railways, that operates Southern Trains, might hold this data.

  • Maria Caulfield – 2016 Parliamentary Question to the Department of Health

    Maria Caulfield – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Maria Caulfield on 2016-01-22.

    To ask the Secretary of State for Health, whether his Department plans to carry out an equality impact assessment of the tender decision on the universal girls vaccination programme for the human papilloma virus; and what the implications are for that programme of a decision to award it to one using the bivalent vaccine.

    Jane Ellison

    The Department has no plans to conduct an equality impact assessment on the tender decision following the on-going re-procurement of human papillomavirus (HPV) vaccine for the adolescent girls programme. The current programme, recommended by the Joint Committee on Vaccination and Immunisation, the expert body that advises the government on all immunisation matters, protects girls against HPV strains 16 and 18 which are responsible for about 70% of cervical cancers.

    The Department and Public Health England are currently undertaking a procurement exercise to secure vaccine to support the girls programme and as this is a competitive tender, it would not be appropriate to pre-judge the outcome of that exercise. The procurement will take account of the costs and benefits of all vaccines offered to establish which provides best value for money for the National Health Service.

  • Maria Caulfield – 2016 Parliamentary Question to the HM Treasury

    Maria Caulfield – 2016 Parliamentary Question to the HM Treasury

    The below Parliamentary question was asked by Maria Caulfield on 2016-04-13.

    To ask Mr Chancellor of the Exchequer, what plans he has to reform the valuation of business rates.

    Greg Hands

    The Budget confirmed that the government will aim to deliver more frequent revaluations. A discussion paper setting out options to deliver this was published last month and can be found on gov.uk. I would encourage those who may be effected to make their views known.